Advertisement
Australia markets close in 4 hours 51 minutes
  • ALL ORDS

    8,485.10
    -13.60 (-0.16%)
     
  • ASX 200

    8,207.80
    -15.20 (-0.18%)
     
  • AUD/USD

    0.6744
    +0.0001 (+0.01%)
     
  • OIL

    75.82
    -0.03 (-0.04%)
     
  • GOLD

    2,651.20
    +11.90 (+0.45%)
     
  • Bitcoin AUD

    89,388.65
    -227.64 (-0.25%)
     
  • XRP AUD

    0.79
    +0.01 (+1.22%)
     
  • AUD/EUR

    0.6165
    +0.0006 (+0.10%)
     
  • AUD/NZD

    1.1058
    +0.0004 (+0.04%)
     
  • NZX 50

    12,764.46
    +9.88 (+0.08%)
     
  • NASDAQ

    20,241.76
    -27.10 (-0.13%)
     
  • FTSE

    8,237.73
    -6.01 (-0.07%)
     
  • Dow Jones

    42,454.12
    -57.88 (-0.14%)
     
  • DAX

    19,210.90
    -44.03 (-0.23%)
     
  • Hang Seng

    21,251.98
    +614.74 (+2.98%)
     
  • NIKKEI 225

    39,493.21
    +112.32 (+0.29%)
     

EBOS Group Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

EBOS Group (NZSE:EBO) Full Year 2024 Results

Key Financial Results

  • Revenue: AU$13.2b (up 7.8% from FY 2023).

  • Net income: AU$271.5m (up 7.2% from FY 2023).

  • Profit margin: 2.1% (in line with FY 2023).

  • EPS: AU$1.41 (up from AU$1.33 in FY 2023).

revenue-and-expenses-breakdown
revenue-and-expenses-breakdown

All figures shown in the chart above are for the trailing 12 month (TTM) period

EBOS Group Revenues Beat Expectations, EPS Falls Short

Revenue exceeded analyst estimates by 1.4%. Earnings per share (EPS) missed analyst estimates by 5.0%.

The primary driver behind last 12 months revenue was the Healthcare segment contributing a total revenue of AU$12.6b (96% of total revenue). Notably, cost of sales worth AU$11.6b amounted to 88% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to AU$567.4m (42% of total expenses). Explore how EBO's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 1.1% p.a. on average during the next 3 years, compared to a 5.8% growth forecast for the Healthcare industry in New Zealand.

Performance of the New Zealander Healthcare industry.

The company's shares are down 2.8% from a week ago.

Risk Analysis

It is worth noting though that we have found 2 warning signs for EBOS Group that you need to take into consideration.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.